Insider Transactions in Q2 2014 at Vyant Bio, Inc. (VYNT)
Insider Transaction List (Q2 2014)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2014
|
John Pappajohn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,288
+3.1%
|
$177,152
$4.0 P/Share
|
|
May 22
2014
|
Keith L Brownlie Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 22
2014
|
Edmund Cannon Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+31.46%
|
-
|
|
May 22
2014
|
Franklyn G Prendergast Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 22
2014
|
John Pappajohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+1.83%
|
-
|
|
May 22
2014
|
Panna Sharma Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
May 22
2014
|
Edward J Sitar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+47.62%
|
-
|
|
May 22
2014
|
Paul Rothman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 21
2014
|
Edward J Sitar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$10,000
$10.67 P/Share
|
|
May 21
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.38%
|
$50,000
$10.66 P/Share
|
|
May 20
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
30,000
+2.24%
|
$300,000
$10.35 P/Share
|
|
May 19
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
15,000
+1.16%
|
$150,000
$10.1 P/Share
|